[go: up one dir, main page]

AR023781A1 - Formulaciones farmaceuticas - Google Patents

Formulaciones farmaceuticas

Info

Publication number
AR023781A1
AR023781A1 ARP000102011A ARP000102011A AR023781A1 AR 023781 A1 AR023781 A1 AR 023781A1 AR P000102011 A ARP000102011 A AR P000102011A AR P000102011 A ARP000102011 A AR P000102011A AR 023781 A1 AR023781 A1 AR 023781A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical formulations
tablet
chewable
ennine
amoxicillin
Prior art date
Application number
ARP000102011A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR023781A1 publication Critical patent/AR023781A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un comprimido masticable que comprende amoxicilina, en el que la base masticable comprende esencialmente manitol, el cual está presente en al menos un 25%en peso del comprimido, es util para tratar una amplia gama de infecciones bacterianas enninos.
ARP000102011A 1999-04-29 2000-04-27 Formulaciones farmaceuticas AR023781A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/301,838 US20020006433A1 (en) 1999-04-29 1999-04-29 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
AR023781A1 true AR023781A1 (es) 2002-09-04

Family

ID=23165119

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102011A AR023781A1 (es) 1999-04-29 2000-04-27 Formulaciones farmaceuticas

Country Status (9)

Country Link
US (1) US20020006433A1 (es)
EP (1) EP1173216A4 (es)
JP (1) JP2002543160A (es)
AR (1) AR023781A1 (es)
AU (1) AU4977300A (es)
CO (1) CO5170455A1 (es)
HK (1) HK1045102A1 (es)
TW (1) TW570804B (es)
WO (1) WO2000066169A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
US8715734B2 (en) * 2004-02-24 2014-05-06 Sandoz Ag Amoxicilline instant granulate
WO2007092031A1 (en) * 2006-02-09 2007-08-16 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulations of montelukast sodium
SI3046548T1 (sl) * 2013-09-20 2020-04-30 Centrient Pharmaceuticals Netherlands B.V. Tableta, ki vsebuje krospovidon
US9254261B2 (en) 2014-03-03 2016-02-09 Sandoz Ag Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid
WO2022133212A1 (en) * 2020-12-18 2022-06-23 Qed Therapeutics, Inc. Methods of treating achondroplasia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them

Also Published As

Publication number Publication date
AU4977300A (en) 2000-11-17
EP1173216A1 (en) 2002-01-23
WO2000066169A1 (en) 2000-11-09
HK1045102A1 (zh) 2002-11-15
US20020006433A1 (en) 2002-01-17
JP2002543160A (ja) 2002-12-17
CO5170455A1 (es) 2002-06-27
EP1173216A4 (en) 2004-09-29
TW570804B (en) 2004-01-11

Similar Documents

Publication Publication Date Title
ES2190692A1 (es) Formulacion farmaceutica de amoxicilina y clavulanato de potasio.
CU20100200A7 (es) Una composición farmacéutica que comprende n-(3,4-difluoro-2-4-iodofenilamino)-6-metoxifenil)-l-(2,3-dihidroxipropil)ciclopropano-l-sulfonamida, útil para el tratamiento y prevención del cáncer y de enfermedades inflamatorias
BR9810320A (pt) Composição farmacêutica sólida, contendo derivados de benzofurano
AR036643A1 (es) Compuestos organicos
BRPI0213653B8 (pt) formulação farmacêutica que contém o 3-(3-dimetil-amino1-etil-2metil-propil) fenol e proporciona uma liberação retardada do ingrediente ativo
BR9611802A (pt) Composições farmacêuticas
TW355683B (en) Composition containing micronized nebivolol
BR0215184A (pt) composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada
BR0307893A (pt) Formulação oftálmica com sistema de goma
BR0309528A (pt) Comprimido com alta carga de droga
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
CL2009001682A1 (es) Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00).
AR023781A1 (es) Formulaciones farmaceuticas
DE69433355D1 (de) Taxane ohne die c-9 oxo gruppe und diese enthaltende pharmazeutische präparate
GT199900154A (es) Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
AR028705A1 (es) Bis-arilsulfonas
PA8515601A1 (es) El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos
CO5050328A1 (es) Sistema solvente para la mejor penetracion de compuestos farmaceuticos
ATE273052T1 (de) Zusammensetzung enthaltend folsäure und zink für das verbessern der semen qualität
AR031649A1 (es) Composicion farmaceutica de dronedarona para administracion parenteral
BR0112847A (pt) Uso de uma forma de dosagem sólida
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
CO5190674A1 (es) Tratamiento de desordenes neuroticos desordenes neuroticos
CO5540294A2 (es) Una combinacion de un derivado de rapamicina y un agente alquilante seleccionado de ciclofosfamida y carmustina y composiciones que las contienen